CervoMed Inc. short interest in 2025
In 2025, CervoMed Inc.'s disclosed short interest ran from 15.07% of shares outstanding on 15 Jan 2025 to 1.64% on 31 Dec 2025, a change of -13.43 percentage points. The year's high was 30.26% on 14 Mar 2025 and its low 1.20% on 14 Nov 2025, averaging 7.70% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.95 days on 14 Feb 2025. Full history: CervoMed Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 15.07% (15 Jan 2025)
- End of year
- 1.64% (31 Dec 2025)
- Change
- -13.43 pp
- High
- 30.26% (14 Mar 2025)
- Low
- 1.20% (14 Nov 2025)
- Average
- 7.70%
- Highest days to cover
- 12.95 (14 Feb 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 15.07% | 5.81 | |
| 31 Jan 2025 | 12.61% | 8.11 | |
| 14 Feb 2025 | 11.70% | 12.95 | |
| 28 Feb 2025 | 10.96% | 12.04 | |
| 14 Mar 2025 | 30.26% | 1.00 | |
| 31 Mar 2025 | 12.71% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 11.17% | 1.06 | |
| 30 Apr 2025 | 10.39% | 2.82 | |
| 15 May 2025 | 10.30% | 2.27 | 10-Q filed, results (8-K) |
| 31 Jul 2025 | 8.37% | 1.00 | |
| 15 Aug 2025 | 3.58% | 1.86 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 3.05% | 2.52 | |
| 15 Sep 2025 | 2.08% | 1.56 | |
| 30 Sep 2025 | 1.96% | 2.11 | |
| 15 Oct 2025 | 2.22% | 1.54 | |
| 31 Oct 2025 | 1.77% | 2.26 | |
| 14 Nov 2025 | 1.20% | 1.76 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 1.38% | 1.19 | |
| 15 Dec 2025 | 1.66% | 2.91 | |
| 31 Dec 2025 | 1.64% | 2.67 |
See also: CervoMed Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.